Medical Cannabis

Medical marijuana has recognised therapeutic applications for chronic pain, epilepsy, sleep disorders, and diabetes management. Cannabis is described as potentially improving chemotherapy tolerance and possibly chemotherapy effectiveness, though not clinically proven. Sublingual sprays combining CBD and THC have demonstrated benefits for glycaemic control and lipid profiles in type II diabetes with minimal side effects. Preliminary research indicates that cannabis-based medicines containing psychoactive Δ9-THC may have therapeutic potential for breathlessness. A majority of Danish survey respondents reported cannabis was considerably more effective than prescription medication and that prescription drug side effects were substantially worse. Cannabis adverse effects include respiratory complications, cardiovascular events, psychiatric disorders, cognitive impairment, and dependency risk. Cannabis is associated with a potentially elevated risk across multiple cancer types, but this association remains inconclusive due to methodological variability across studies. In Denmark, doctors may legally prescribe cannabis for selected conditions including multiple sclerosis, chronic pain an…